Editorial: early post-induction anti-TNF drug monitoring can predict long-term therapeutic outcomes in inflammatory bowel disease

K. Papamichael, A. S. Cheifetz
  • Alimentary Pharmacology & Therapeutics, January 2018, Wiley
  • DOI: 10.1111/apt.14461
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Konstantinos Papamichail